859. Suboptimal Uptake, Retention, and Adherence of Daily Oral PrEP Among People with OUD Receiving HCV Treatment

BACKGROUND: Daily oral pre-exposure prophylaxis (PrEP) with tenofovir/emtricitabine (TDF/FTC) effectively prevents HIV among people who use drugs (PWUD). Despite rising rates of HIV incidence and injection drug use, PrEP use remains low and limited research exists on PrEP adherence and retention in...

Descripción completa

Detalles Bibliográficos
Autores principales: Brokus, Christopher J, Stevens, Jasmine, Silk, Rachel, Mount, Julia, Gannon, Catherine, Eyasu, Rahwa, Davis, Ashley, Cover, Amelia, Ebah, Emade, Gayle, Britt, Ogbumbadiugha-Weekes, Onyinyechi, Narayanan, Shivakumar, Bijole, Phyllis, Jones, Miriam, Kier, Randy, Sternberg, David, Masur, Henry, Kottilil, Shyam, Kattakuzhy, Sarah, Rosenthal, Elana S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644479/
http://dx.doi.org/10.1093/ofid/ofab466.1054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644479/
http://dx.doi.org/10.1093/ofid/ofab466.1054

Ejemplares similares